{"id":"https://openalex.org/W2809354512","doi":"https://doi.org/10.2337/db18-1154-p","title":"Influence of SGLT2 Inhibitor on Resting Heart Rate (RHR) and Factors Related to Its Changes","display_name":"Influence of SGLT2 Inhibitor on Resting Heart Rate (RHR) and Factors Related to Its Changes","publication_year":2018,"publication_date":"2018-06-22","ids":{"openalex":"https://openalex.org/W2809354512","doi":"https://doi.org/10.2337/db18-1154-p","mag":"2809354512"},"language":"en","primary_location":{"id":"doi:10.2337/db18-1154-p","doi":"https://doi.org/10.2337/db18-1154-p","is_oa":false,"landing_page_url":"https://doi.org/10.2337/db18-1154-p","pdf_url":null,"source":{"id":"https://openalex.org/S129060628","display_name":"Diabetes","issn_l":"0012-1797","issn":["0012-1797","1939-327X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034811420","display_name":"Yasuhiro Matsubayashi","orcid":"https://orcid.org/0000-0002-2143-1921","observed_orcids":["https://orcid.org/0000-0002-2143-1921"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"YASUHIRO MATSUBAYASHI","raw_affiliation_strings":["Niigata, Japan, Tokyo, Japan, Kyoto, Japan, Kurashiki, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Niigata, Japan, Tokyo, Japan, Kyoto, Japan, Kurashiki, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071183903","display_name":"Toshiaki Nojima","orcid":"https://orcid.org/0000-0001-9717-985X","observed_orcids":["https://orcid.org/0000-0001-9717-985X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"TOSHIAKI NOJIMA","raw_affiliation_strings":["Niigata, Japan, Tokyo, Japan, Kyoto, Japan, Kurashiki, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Niigata, Japan, Tokyo, Japan, Kyoto, Japan, Kurashiki, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"AKIHIRO YOSHIDA","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"AKIHIRO YOSHIDA","raw_affiliation_strings":["Niigata, Japan, Tokyo, Japan, Kyoto, Japan, Kurashiki, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Niigata, Japan, Tokyo, Japan, Kyoto, Japan, Kurashiki, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012076071","display_name":"Hideki Suganami","orcid":"https://orcid.org/0000-0001-9130-0137","observed_orcids":["https://orcid.org/0000-0001-9130-0137"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"HIDEKI SUGANAMI","raw_affiliation_strings":["Niigata, Japan, Tokyo, Japan, Kyoto, Japan, Kurashiki, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Niigata, Japan, Tokyo, Japan, Kyoto, Japan, Kurashiki, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007023852","display_name":"Takaho Yamada","orcid":"https://orcid.org/0000-0002-8484-570X","observed_orcids":["https://orcid.org/0000-0002-8484-570X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"TAKAHO YAMADA","raw_affiliation_strings":["Niigata, Japan, Tokyo, Japan, Kyoto, Japan, Kurashiki, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Niigata, Japan, Tokyo, Japan, Kyoto, Japan, Kurashiki, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101825283","display_name":"Kazuya Fujihara","orcid":"https://orcid.org/0000-0002-9859-389X","observed_orcids":["https://orcid.org/0000-0002-9859-389X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"KAZUYA FUJIHARA","raw_affiliation_strings":["Niigata, Japan, Tokyo, Japan, Kyoto, Japan, Kurashiki, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Niigata, Japan, Tokyo, Japan, Kyoto, Japan, Kurashiki, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081339326","display_name":"Shiro Tanaka","orcid":"https://orcid.org/0000-0001-6817-5235","observed_orcids":["https://orcid.org/0000-0001-6817-5235"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"SHIRO TANAKA","raw_affiliation_strings":["Niigata, Japan, Tokyo, Japan, Kyoto, Japan, Kurashiki, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Niigata, Japan, Tokyo, Japan, Kyoto, Japan, Kurashiki, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036190568","display_name":"Kohei Kaku","orcid":"https://orcid.org/0000-0003-1574-0565","observed_orcids":["https://orcid.org/0000-0003-1574-0565"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"KOHEI KAKU","raw_affiliation_strings":["Niigata, Japan, Tokyo, Japan, Kyoto, Japan, Kurashiki, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Niigata, Japan, Tokyo, Japan, Kyoto, Japan, Kurashiki, Japan","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5037174575","display_name":"Hirohito Sone","orcid":"https://orcid.org/0000-0003-1263-2817","observed_orcids":["https://orcid.org/0000-0003-1263-2817"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"HIROHITO SONE","raw_affiliation_strings":["Niigata, Japan, Tokyo, Japan, Kyoto, Japan, Kurashiki, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Niigata, Japan, Tokyo, Japan, Kyoto, Japan, Kurashiki, Japan","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.6408,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":{"value":0.83761104,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"67","issue":"Supplement_1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13381","display_name":"Heart rate and cardiovascular health","score":0.00279999990016222,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.9549999833106995},{"id":"https://openalex.org/keywords/tofogliflozin","display_name":"tofogliflozin","score":0.9829999804496765},{"id":"https://openalex.org/keywords/resting-heart-rate","display_name":"resting heart rate","score":0.9990000128746033},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9919999837875366},{"id":"https://openalex.org/keywords/adipose-tissue-insulin-resistance","display_name":"adipose tissue insulin resistance","score":0.9860000014305115},{"id":"https://openalex.org/keywords/sympathetic-nervous-system","display_name":"sympathetic nervous system","score":0.8389999866485596},{"id":"https://openalex.org/keywords/cardiovascular-risk","display_name":"cardiovascular risk","score":0.6060000061988831},{"id":"https://openalex.org/keywords/renal-risk","display_name":"renal risk","score":0.3840000033378601},{"id":"https://openalex.org/keywords/free-fatty-acids","display_name":"free fatty acids","score":0.550000011920929},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.43799999356269836},{"id":"https://openalex.org/keywords/diet-and-exercise-therapy","display_name":"diet and exercise therapy","score":0.671999990940094},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.7699999809265137},{"id":"https://openalex.org/keywords/body-weight","display_name":"body weight","score":0.7300000190734863},{"id":"https://openalex.org/keywords/systolic-blood-pressure","display_name":"systolic blood pressure","score":0.9679999947547913},{"id":"https://openalex.org/keywords/baseline-heart-rate","display_name":"baseline heart rate","score":0.421999990940094}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7424314022064209},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7078704833984375},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6780380010604858},{"id":"https://openalex.org/C68443243","wikidata":"https://www.wikidata.org/wiki/Q2786686","display_name":"Quartile","level":3,"score":0.6052502393722534},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5347904562950134},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5056657791137695},{"id":"https://openalex.org/C2911194756","wikidata":"https://www.wikidata.org/wiki/Q1073121","display_name":"RESTING HEART RATE","level":4,"score":0.4909115433692932},{"id":"https://openalex.org/C2777953023","wikidata":"https://www.wikidata.org/wiki/Q1073121","display_name":"Heart rate","level":3,"score":0.49054163694381714},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.4498906135559082},{"id":"https://openalex.org/C2777391703","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin resistance","level":3,"score":0.44777438044548035},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.4132981598377228},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.13592517375946045},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.13174986839294434},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.2337/db18-1154-p","doi":"https://doi.org/10.2337/db18-1154-p","is_oa":false,"landing_page_url":"https://doi.org/10.2337/db18-1154-p","pdf_url":null,"source":{"id":"https://openalex.org/S129060628","display_name":"Diabetes","issn_l":"0012-1797","issn":["0012-1797","1939-327X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3006821885","https://openalex.org/W2801815064","https://openalex.org/W7160820365","https://openalex.org/W4401893245","https://openalex.org/W2343926085","https://openalex.org/W4389622228","https://openalex.org/W4380149001","https://openalex.org/W4394848764","https://openalex.org/W7221041786","https://openalex.org/W4234658701"],"abstract_inverted_index":{"An":[0],"elevated":[1],"resting":[2],"heart":[3,123],"rate":[4],"(RHR)":[5],"is":[6],"a":[7,90,275],"risk":[8],"factor":[9],"for":[10],"vascular":[11],"complications":[12],"in":[13,38,67,69,95,122,150,204,222,232,254,278,307],"patients":[14,70,77],"with":[15,71,133,148,230,244,274,298],"and":[16,33,60,80,100,118,128,172,189,200,217,236,251,266,292,309,425],"without":[17],"type":[18],"2":[19,99],"diabetes":[20],"mellitus":[21],"(T2DM).":[22],"Recently,":[23],"the":[24,54,61,111,129,177,252,284,288,301],"beneficial":[25,285],"effects":[26,178,286],"of":[27,56,113,206,287,300,311],"SGLT2":[28],"inhibitors":[29],"(SGLT2i)":[30],"on":[31,58,78,179,290],"cardiovascular":[32,291],"renal":[34,293],"events":[35,294],"were":[36,74,131,146,213,271],"reported":[37],"large-scale":[39],"clinical":[40,62],"trials.":[41],"However,":[42],"their":[43],"mechanisms":[44],"are":[45],"not":[46,228],"fully":[47],"clarified.":[48],"This":[49],"study":[50],"aimed":[51],"to":[52,141,210],"investigate":[53],"effect":[55],"SGLT2i":[57,289],"RHR":[59,68,166,183,207,223,246],"factors":[63,144],"that":[64,145,263,283],"affect":[65],"changes":[66,149,231],"T2DM.":[72],"Analyzed":[73],"419":[75],"T2DM":[76],"diet":[79],"exercise":[81],"therapy":[82],"who":[83],"received":[84],"an":[85,134],"SGLT2i,":[86],"tofogliflozin":[87],"(TOFO),":[88],"or":[89],"placebo":[91,130],"as":[92],"initial":[93],"monotherapy":[94],"two":[96],"TOFO":[97,127,181],"phase":[98],"3":[101],"studies.":[102],"Adipose":[103],"tissue":[104],"insulin":[105],"resistance":[106],"(Adipo-IR)":[107],"was":[108,139,242],"calculated":[109],"by":[110,305],"product":[112],"fasting":[114,119],"free":[115],"fatty":[116],"acid":[117],"insulin.":[120],"Differences":[121],"rate-related":[124],"variables":[125],"between":[126],"analyzed":[132],"ANCOVA":[135],"model.":[136],"Multivariate":[137,260],"analysis":[138,261],"performed":[140],"clarify":[142],"independent":[143],"associated":[147,273,297],"RHR.":[151,279],"Baseline":[152],"characteristics":[153],"were:":[154],"male":[155],"(67%),":[156],"age":[157],"(mean:":[158],"58":[159],"years),":[160],"HbA1c":[161],"(8.1%),":[162],"BMI":[163],"(26":[164],"kg/m2),":[165],"(66":[167],"bpm),":[168],"eGFR":[169],"(84":[170],"mL/min/1.73m2)":[171],"Adipo-IR":[173,255,267,308],"(32.5":[174],"pmol/L\u2022mmol/L).":[175],"Concerning":[176],"RHR,":[180],"reduced":[182],"levels":[184,247,268],"(least":[185],"squares":[186],"mean:":[187],"-1.7":[188],"-1.1":[190],"bpm,":[191],"p<0.01":[192],"vs.":[193],"baseline,":[194],"p<0.vs.":[195],"placebo)":[196],"at":[197,224,269],"weeks":[198,212],"12":[199],"24,":[201],"respectively.":[202,219],"Changes":[203],"quartiles":[205],"from":[208],"baseline":[209,245,270],"24":[211,226],"7.7,":[214],"0.7,":[215],"-3.7,":[216],"-11.2,":[218],"The":[220],"change":[221,253],"week":[225],"did":[227],"correlate":[229],"HbA1c,":[233],"body":[234],"weight":[235],"systolic":[237],"blood":[238],"pressure;":[239],"however,":[240],"it":[241],"correlated":[243],"(r":[248,256],"=":[249,257],"-0.37)":[250],"0.39)":[258],"significantly.":[259],"indicated":[262],"higher":[264],"RHRs":[265],"independently":[272],"greater":[276],"reduction":[277],"Our":[280],"results":[281],"showed":[282],"may":[295],"be":[296],"suppression":[299],"sympathetic":[302],"nervous":[303],"system":[304],"improvement":[306],"amelioration":[310],"hyperinsulinemia.":[312],"Disclosure":[313],"Y.":[314],"Matsubayashi:":[315],"None.":[316,340,343,346],"T.":[317,338],"Nojima:":[318],"Employee;":[319,325,333],"Self;":[320,326,334,351,355,361,370,376,383,391,411,419],"Kowa":[321,327,335,405,457],"Company,LTD.":[322],"A.":[323],"Yoshida:":[324],"Pharmaceutical":[328,378,393,430,434,448],"Co.":[329],"Ltd.":[330],"H.":[331,415],"Suganami:":[332],"Company,":[336,426,445],"Ltd..":[337,380,388],"Yamada:":[339],"K.":[341,347],"Fujihara:":[342],"S.":[344],"Tanaka:":[345],"Kaku:":[348],"Speaker's":[349,359,374,389],"Bureau;":[350,360,375,390],"AstraZeneca.":[352],"Advisory":[353,368,381,409],"Panel;":[354,369,382,410],"Boehringer":[356],"Ingelheim":[357],"GmbH.":[358],"Mitsubishi":[362],"Tanabe":[363],"Pharma":[364,398],"Corporation,":[365],"MSD":[366,427],"K.K..":[367],"Novo":[371,420],"Nordisk":[372,421],"A/S.":[373],"Ono":[377,447],"Co.,":[379,387,394,399,431,435,449,454],"Sanwa":[384],"Kagaku":[385],"Kenkyusho":[386],"Taisho":[392,433],"Ltd.,":[395,400,432,436,442,450,455],"Sumitomo":[396],"Dainippon":[397],"Takeda":[401,437],"Pharmaceuticals,":[402,406],"Japan":[403,407,413],"Inc.,":[404,422,460],"Inc..":[408,462],"Astellas,":[412],"Inc.":[414],"Sone:":[416],"Research":[417],"Support;":[418],"Eli":[423],"Lilly":[424],"K.K.,":[428],"Chugai":[429],"Development":[438],"Center":[439],"Asia,":[440],"Pte.":[441],"Daiichi":[443],"Sankyo":[444],"Limited,":[446],"Kyowa":[451],"Hakko":[452],"Kirin":[453],"Sanofi,":[456],"Pharmaceuticals":[458],"America,":[459],"Eisai":[461]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2018-06-29T00:00:00"}